Understanding Your Acromegaly Diagnosis
At a Glance
Acromegaly usually results from a benign pituitary adenoma that produces too much growth hormone. This signals the liver to make IGF-1, which drives gradual tissue growth, so symptoms can resemble aging or common conditions and delay diagnosis for years.
Receiving a diagnosis of acromegaly can feel like the end of a long and confusing journey. For many, this moment brings a mix of relief that the symptoms finally have a name and frustration that it took so long to get here. Understanding the biological “why” behind your symptoms and the reality of how this rare disease is diagnosed can help you navigate the next steps of your care.
A Long Road to Answers
If you spent years visiting different doctors for seemingly unrelated issues—like joint pain, snoring, or changes in your shoe size—before being diagnosed, you are not alone. This “diagnostic odyssey” is a hallmark of acromegaly. Because the physical changes happen so slowly, they are often mistaken for normal aging or more common conditions [1].
On average, it takes about five years from the first onset of symptoms to a confirmed diagnosis, and for some, the delay can stretch to 10 years or more [1][2]. Fewer than 15% of patients initially seek care specifically for the changes in their appearance; instead, the diagnosis often comes after seeking help for systemic issues like sleep apnea or diabetes [2].
How Rare Is It?
Acromegaly is considered a rare disease, but its exact frequency is still being refined by modern medicine. Historically, the incidence (the number of new cases diagnosed each year) was estimated to be about 11 people per million [3]. However, newer research using healthcare registries suggests the prevalence (the total number of people currently living with the condition) may be up to 122 people per million [4].
This increase in numbers is likely due to better awareness among doctors and improved diagnostic tools that catch the disease earlier [4][5]. Even so, acromegaly remains rare enough that many general practitioners may only see one or two cases in their entire career.
The Biological Mechanism
The symptoms of acromegaly are driven by a specific hormonal chain reaction. It begins in the pituitary gland, a pea-sized organ at the base of your brain that acts as your body’s “master gland.”
- The Adenoma: In 95% to 98% of cases, a pituitary adenoma (a benign, non-cancerous tumor) develops [6]. These tumors are usually sporadic, meaning they occur by chance rather than being inherited [7].
- Growth Hormone (GH) Overproduction: The cells within this tumor begin to overproduce growth hormone (GH). In a healthy body, GH is released in pulses throughout the day; in acromegaly, the tumor pumps out GH continuously and at much higher levels than the body needs [7].
- The Liver and IGF-1: The excess GH travels through the bloodstream to the liver. There, it triggers the production of another hormone called insulin-like growth factor-1 (IGF-1) [7].
- Systemic Growth: While GH starts the process, IGF-1 is responsible for most of the actual tissue growth. It causes bones, soft tissues, and organs to enlarge, leading to the physical changes you may have noticed [7].
Knowns and Unknowns
While we understand the hormone pathway well, the “why” behind the tumor’s initial growth is still a subject of intense research.
- What is known: Molecular changes (somatic mutations) are found in some tumors, meaning they occur after birth [7].
- What is unknown: The exact cause of most individual tumors remains unknown. It is not caused by lifestyle, diet, or environmental factors that you could have controlled [7].
- Genetics: A small percentage of cases are linked to inherited genetic syndromes, especially when the disease appears in children or young adults [7].
The Emotional Impact
The long delay in diagnosis often takes a toll that goes beyond the physical. It is common to feel dismissed, frustrated, or angry after years of symptoms being misdiagnosed [8][9].
Studies show that anxiety and depression are significantly more common in people with acromegaly than in the general population, affecting roughly 30% to 66% of patients [10][11]. These feelings are often tied to body-image distress, persistent fatigue, and the sheer mental exhaustion of managing a chronic, rare condition [12][10]. Recognizing that these emotional struggles are a documented part of the disease is an important step in your overall care. Do not hesitate to ask your medical team for mental health support or a referral to a counselor who specializes in chronic illnesses.
Common questions in this guide
Why does acromegaly often take so long to diagnose?
What usually causes acromegaly?
What is the relationship between growth hormone and IGF-1 in acromegaly?
Is acromegaly inherited, and should my family be tested?
Can acromegaly affect mental health?
How common is acromegaly?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Why did my symptoms take so long to point to this diagnosis, and were there specific signs that were missed?
- 2.Is my tumor a microadenoma or a macroadenoma, and how does its size affect my treatment plan?
- 3.Are there signs that my condition might be related to a genetic predisposition, and should my family members be tested?
- 4.How will you monitor both my GH and IGF-1 levels, and what happens if these two numbers don't agree?
- 5.Can you refer me to a multidisciplinary pituitary center or an endocrinologist who specializes specifically in acromegaly?
- 6.How do we address the non-physical symptoms, like my mood and energy levels, alongside my hormone numbers?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Ends of the spectrum best practices for early detection and multidisciplinary management of acromegaly.
Cheok SK, Tavakoli-Sabour S, Beck RT, et al.
Journal of neuro-oncology 2025; (171(1)):1-9 doi:10.1007/s11060-024-04833-w.
PMID: 39607571 - 2
Acromegaly: clinical features at diagnosis.
Vilar L, Vilar CF, Lyra R, et al.
Pituitary 2017; (20(1)):22-32 doi:10.1007/s11102-016-0772-8.
PMID: 27812777 - 3
Incidence and prevalence of acromegaly in a large US health plan database.
Burton T, Le Nestour E, Neary M, Ludlam WH
Pituitary 2016; (19(3)):262-7 doi:10.1007/s11102-015-0701-2.
PMID: 26792654 - 4
The prevalence of acromegaly is higher than previously reported: Changes over a three-decade period.
Aagaard C, Christophersen AS, Finnerup S, et al.
Clinical endocrinology 2022; (97(6)):773-782 doi:10.1111/cen.14828.
PMID: 36163677 - 5
Acromegaly.
Colao A, Grasso LFS, Giustina A, et al.
Nature reviews. Disease primers 2019; (5(1)):20 doi:10.1038/s41572-019-0071-6.
PMID: 30899019 - 6
Global epidemiology of acromegaly: a systematic review and meta-analysis.
Crisafulli S, Luxi N, Sultana J, et al.
European journal of endocrinology 2021; (185(2)):251-263.
PMID: 34061771 - 7
Acromegaly: pathogenesis, diagnosis, and management.
Fleseriu M, Langlois F, Lim DST, et al.
The lancet. Diabetes & endocrinology 2022; (10(11)):804-826 doi:10.1016/S2213-8587(22)00244-3.
PMID: 36209758 - 8
PREDICTORS OF QUALITY OF LIFE IN 165 PATIENTS WITH ACROMEGALY: RESULTS FROM A SINGLE-CENTER STUDY.
Kreitschmann-Andermahr I, Buchfelder M, Kleist B, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017; (23(1)):79-88 doi:10.4158/EP161373.OR.
PMID: 27749131 - 9
Patients' perspectives on acromegaly diagnostic delay: a qualitative study.
Sibeoni J, Manolios E, Verneuil L, et al.
European journal of endocrinology 2019; (180(6)):339-352.
PMID: 30939451 - 10
Anxiety, depression and acromegaly: a systematic review.
Silvestro O, Lund-Jacobsen T, Ferraù F, et al.
Journal of endocrinological investigation 2025; (48(3)):527-546 doi:10.1007/s40618-024-02483-3.
PMID: 39509066 - 11
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study.
Pivonello R, Auriemma RS, Delli Veneri A, et al.
European journal of endocrinology 2022; (187(6)):823-845 doi:10.1530/EJE-22-0263.
PMID: 36165745 - 12
Variables Associated With Body Image Concerns in Acromegaly Patients: A Cross-Sectional Study.
Zhang X, Li Y, Zhong Y, Wang Z
Frontiers in psychology 2022; (13()):733864 doi:10.3389/fpsyg.2022.733864.
PMID: 35756208
This page is for informational purposes only and does not constitute medical advice. Your endocrinologist or pituitary specialist can interpret your GH and IGF-1 results and guide care for your situation.
Get notified when new evidence is published on growth hormone-producing pituitary gland neoplasm.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.